Clin Mol Hepatol > Accepted Articles
Reply: Correspondence: “Transcriptomic signature in hepatocellular carcinoma to predict immunotherapy response.”
Hiroaki Kanzaki1,2, Yujin Hoshida2
1Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan
2Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, U.S.
Correspondence :  Yujin Hoshida ,
Email: Yujin.Hoshida@UTSouthwestern.edu
Received: October 8, 2024   Accepted: October 9, 2024
KeyWords: hepatocellular carcinoma; immunotherapy; predictive biomarker; tumor immune microenvironment

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 1340
TOTAL : 2173997
Close layer